Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global blood plasma derivatives market reached a value of US$ 40.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 59.8 Billion by 2027, exhibiting a CAGR of 6.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.
Blood Plasma Derivatives Market Trends:
The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood plasma derivatives market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Breakup by Application:
Hemophilia
Hypogammaglobulinemia
Immunodeficiency Diseases
Von Willebrand's Disease
Others
Breakup by End User:
Hospitals
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited. Key Questions Answered in This Report:
How has the global blood plasma derivatives market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global blood plasma derivatives market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global blood plasma derivatives market and who are the key players?
What is the degree of competition in the industry?
Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.
Blood Plasma Derivatives Market Trends:
The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood plasma derivatives market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Breakup by Application:
Hemophilia
Hypogammaglobulinemia
Immunodeficiency Diseases
Von Willebrand's Disease
Others
Breakup by End User:
Hospitals
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited. Key Questions Answered in This Report:
How has the global blood plasma derivatives market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global blood plasma derivatives market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global blood plasma derivatives market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BLOOD PLASMA DERIVATIVES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Albumin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Factor VIII
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Factor IX
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Immunoglobulin
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Hyperimmune Globulin
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Hemophilia
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hypogammaglobulinemia
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunodeficiency Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Von Willebrand's Disease
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 CSL Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Fusion Health Care Pvt. Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Grifols S.A.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Kedrion S.p.A.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 LFB S.A.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Octapharma AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BLOOD PLASMA DERIVATIVES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Albumin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Factor VIII
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Factor IX
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Immunoglobulin
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Hyperimmune Globulin
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Hemophilia
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hypogammaglobulinemia
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunodeficiency Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Von Willebrand's Disease
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 CSL Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Fusion Health Care Pvt. Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Grifols S.A.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Kedrion S.p.A.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 LFB S.A.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Octapharma AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
Table 7: Global: Blood Plasma Derivatives Market: Key Players
Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
Table 7: Global: Blood Plasma Derivatives Market: Key Players
LIST OF FIGURES
Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2021
Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2021
Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2021
Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2021
Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis
Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2021
Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2021
Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2021
Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2021
Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis
